|
|
FIN 2014
COI 3.09 %
Breed relevant health information:
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA)
N/mut (carrier)
|
FIN 2011
COI 8.07 %
Breed relevant health information:
Hips
Fair / B1 / 4-6 / B / 11-18
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
FIN 2012
COI 3.49 %
*
Breed relevant health information:
Elbows
Grades 1/1
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA)
N/mut (carrier)
|
|||
|
SWE 2011
COI 3.77 %
*
Breed relevant health information:
Hips
Fair / B1 / 4-6 / B / 11-18
|
||
FIN 2009
COI 1.57 %
*
Other health issues and screening results:
Mammary tumors
Year of death:
2019
Cause of death:
Mammary tumors
|
|||
|
FIN 2013
COI 7.60 %
Other health issues and screening results:
Unspecified/Other Eye Disease
|
FIN 2004
COI 2.93 %
*
Breed relevant health information:
Hips
Mild / C1 / 9-12 / C / 26-35
Progressive retinal atrophy (prcd-PRA)
N/mut (carrier)
Year of death:
2020
Cause of death:
Old age (unspecified cause of death)
|
|
|
|||
FIN 2013
COI 1.11 %
Other health issues and screening results:
Mammary tumors
Year of death:
2024
Cause of death:
Mammary tumors
|
FIN 2011
COI 4.94 %
*
Breed relevant health information:
Hips
Mild / C1 / 9-12 / C / 26-35
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
||
|